Warning: Creating default object from empty value in /home/altaywgm/public_html/wp-content/plugins/gaviasframework/redux/redux-framework/inc/class.redux_filesystem.php on line 29
New Indication: Atezolizumab for early-stage NSCLC - Altai Oncology

Altai Protocol Library

1041 protocols and counting

All protocols with references and links

All protocols reviewed by a Medical Oncologist/Hematologist

All protocols in major guidelines included

Ability to create your own protocols

Kütüphanede Ara Ara

New Indication: Atezolizumab for early-stage NSCLC

New Indication: Atezolizumab for early-stage NSCLC
  • Open-label Phase III trial (IMpower010)
  • Completely resected early-stage NSCLC s/p adjuvant platinum-based chemo
  • Atezolizumab 1200 q21 x 1 yr vs. best supportive care
  • Among pts with stage II-IIIA & PD-L1 >= 1% => 3-year DFS: 60.0% vs. 48.2% (HR: 0.66 [0.50-0.88])
  • Among all pts with stage II-IIIA => 3-yr DFS: 55.7% vs. 49.4% (HR: 0.79 [0.64-0.96])
  • Grade >=3 AEs: All (21.8% vs. 11.5%)

Lancet. Published Online on Sep 20, 2021

Felip E, et al. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial


Altai Chemo Planner

Quickly Prepare Accurate Chemotherapy Orders

Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.

Learn More